Prudential Financial Inc. lessened its holdings in LifePoint Health, Inc. (NASDAQ:LPNT) by 27.5% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 467,492 shares of the company’s stock after selling 177,549 shares during the period. Prudential Financial Inc. owned approximately 1.17% of LifePoint Health worth $27,068,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors have also made changes to their positions in the company. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in shares of LifePoint Health by 10.8% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,678 shares of the company’s stock valued at $113,000 after purchasing an additional 164 shares during the last quarter. LS Investment Advisors LLC lifted its stake in shares of LifePoint Health by 43.7% in the 2nd quarter. LS Investment Advisors LLC now owns 1,785 shares of the company’s stock valued at $120,000 after purchasing an additional 543 shares during the last quarter. US Bancorp DE lifted its stake in shares of LifePoint Health by 0.8% in the 2nd quarter. US Bancorp DE now owns 1,947 shares of the company’s stock valued at $130,000 after purchasing an additional 16 shares during the last quarter. Shelton Capital Management acquired a new position in shares of LifePoint Health in the 2nd quarter valued at $205,000. Finally, Teacher Retirement System of Texas lifted its stake in shares of LifePoint Health by 0.3% in the 2nd quarter. Teacher Retirement System of Texas now owns 3,211 shares of the company’s stock valued at $216,000 after purchasing an additional 9 shares during the last quarter. 99.18% of the stock is currently owned by institutional investors and hedge funds.
Shares of LifePoint Health, Inc. (NASDAQ LPNT) opened at $43.55 on Thursday. The company has a current ratio of 1.85, a quick ratio of 1.65 and a debt-to-equity ratio of 1.24. LifePoint Health, Inc. has a 1-year low of $42.50 and a 1-year high of $70.95. The firm has a market capitalization of $1,714.59, a PE ratio of 11.10, a price-to-earnings-growth ratio of 1.13 and a beta of 0.68.
LifePoint Health (NASDAQ:LPNT) last issued its quarterly earnings results on Friday, October 27th. The company reported $0.80 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.95 by ($0.15). LifePoint Health had a return on equity of 7.01% and a net margin of 2.45%. The company had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.60 billion. During the same quarter last year, the company earned $0.94 EPS. LifePoint Health’s revenue for the quarter was down .7% compared to the same quarter last year. equities analysts expect that LifePoint Health, Inc. will post 3.65 earnings per share for the current year.
LifePoint Health declared that its board has initiated a stock buyback program on Friday, October 27th that allows the company to buyback $200.00 million in shares. This buyback authorization allows the company to purchase shares of its stock through open market purchases. Shares buyback programs are generally an indication that the company’s board believes its stock is undervalued.
LPNT has been the topic of several recent analyst reports. Robert W. Baird set a $69.00 price target on LifePoint Health and gave the company a “buy” rating in a research note on Thursday, October 12th. ValuEngine upgraded LifePoint Health from a “hold” rating to a “buy” rating in a report on Thursday, August 17th. Citigroup Inc. cut their price objective on LifePoint Health from $70.00 to $60.00 and set a “buy” rating on the stock in a report on Monday, October 30th. TheStreet downgraded LifePoint Health from a “b-” rating to a “c+” rating in a report on Wednesday, August 16th. Finally, Zacks Investment Research upgraded LifePoint Health from a “sell” rating to a “hold” rating in a report on Monday, August 21st. Two investment analysts have rated the stock with a sell rating, twelve have given a hold rating and four have issued a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $60.23.
About LifePoint Health
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
Receive News & Ratings for LifePoint Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.